News
PLRZ
10.19
-10.06%
-1.14
Weekly Report: what happened at PLRZ last week (0803-0807)?
Weekly Report · 1d ago
Weekly Report: what happened at PLRZ last week (0727-0731)?
Weekly Report · 08/03 09:53
Weekly Report: what happened at PLRZ last week (0720-0724)?
Weekly Report · 07/27 09:56
Weekly Report: what happened at PLRZ last week (0713-0717)?
Weekly Report · 07/20 09:54
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 07/14 12:05
Polyrizon Shareholders Approve New Executive Compensation Policy on July 13, 2026
TipRanks · 07/13 20:59
Weekly Report: what happened at PLRZ last week (0706-0710)?
Weekly Report · 07/13 09:55
Weekly Report: what happened at PLRZ last week (0629-0703)?
Weekly Report · 07/06 09:58
Polyrizon Clears Key Safety Milestone for NASARIX Allergy Nasal Spray
TipRanks · 07/02 20:28
Polyrizon Reports NASARIX Biocompatibility Results, Supporting Advancement To First-In-Human Clinical Trial
Benzinga · 07/02 20:13
Morning Movers: Lindsay climbs following quarterly report
TipRanks · 07/02 12:55
Polyrizon announces results from Nasarix biocompatibility evaluation program
TipRanks · 07/02 11:40
Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial
Barchart · 07/02 06:32
Polyrizon Wins Central IRB Nod for First NASARIX Allergy Blocker Trial
TipRanks · 06/29 20:29
Polyrizon Gains Central IRB Approval For First-in-Human NASARIX Trial In Allergic Rhinitis; Stock Up
NASDAQ · 06/29 14:32
Polyrizon receives central IRB approval for Nasarix
TipRanks · 06/29 13:15
Polyrizon Receives Central IRB Approval To Begin First Human Clinical Trial For NASARIX, Nasal Spray Designed To Block Airborne Allergens
Benzinga · 06/29 12:45
Weekly Report: what happened at PLRZ last week (0622-0626)?
Weekly Report · 06/29 09:54
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial
Barchart · 06/29 07:44
Weekly Report: what happened at PLRZ last week (0615-0619)?
Weekly Report · 06/22 10:01
More
Webull provides a variety of real-time PLRZ stock news. You can receive the latest news about Polyrizon Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PLRZ
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..